Report Overview
Health care professionals use the Body Mass Index (BMI), a measure of people weight in relation to height, to define overweight and obesity. People who have a BMI between 25 and 30 are considered to be overweight. Obesity is defined as having a BMI of 30 or greater. Are overweight, obese, or severely obese, which may increase risk of developing health problems. Obesity is a chronic disease and prescription medications to treat overweight and obesity work in different ways. Prescription weight loss medicines can help obese people lose weight. They are usually prescribed by a doctor when diet and exercise alone are not working. Each of these medicines works differently. People who use these medicines may not feel as hungry. Or they may feel full after eating only a small amount of food. Another type of weight-loss medicine makes it harder for your body to absorb fat. Prescription weight loss drugs can be helpful when used in combination with a low-calorie diet and regular physical activity.
The global Prescription Weight Loss Pills market size was estimated at USD 1130 million in 2023 and is projected to reach USD 2752.96 million by 2032, exhibiting a CAGR of 10.40% during the forecast period.
North America Prescription Weight Loss Pills market size was estimated at USD 349.28 million in 2023, at a CAGR of 8.91% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Prescription Weight Loss Pills market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Prescription Weight Loss Pills Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Prescription Weight Loss Pills market in any manner.
Global Prescription Weight Loss Pills Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Currax Pharmaceuticals (Contrave)
VIVUS (Qsymia)
Novo Nordisk A/S
Rhythm Pharmaceuticals (Imcivree)
Eli Lilly and Company (TRICARE)
CHEPLAPHARM (Xenical)
Pfizer
Teva Pharmaceutical (Actavis)
Haleon Group (alli)
Sanofi (Adlyxin)
AstraZeneca (BYDUREON BCise)
Market Segmentation (by Type)
Oral Tablets
Oral Capsules
Injections
Market Segmentation (by Application)
Hospital
Pharmacy
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Prescription Weight Loss Pills Market
Overview of the regional outlook of the Prescription Weight Loss Pills Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Prescription Weight Loss Pills Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Prescription Weight Loss Pills, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Prescription Weight Loss Pills
1.2 Key Market Segments
1.2.1 Prescription Weight Loss Pills Segment by Type
1.2.2 Prescription Weight Loss Pills Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Prescription Weight Loss Pills Market Overview
2.1 Global Market Overview
2.1.1 Global Prescription Weight Loss Pills Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Prescription Weight Loss Pills Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Prescription Weight Loss Pills Market Competitive Landscape
3.1 Global Prescription Weight Loss Pills Sales by Manufacturers (2019-2025)
3.2 Global Prescription Weight Loss Pills Revenue Market Share by Manufacturers (2019-2025)
3.3 Prescription Weight Loss Pills Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Prescription Weight Loss Pills Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Prescription Weight Loss Pills Sales Sites, Area Served, Product Type
3.6 Prescription Weight Loss Pills Market Competitive Situation and Trends
3.6.1 Prescription Weight Loss Pills Market Concentration Rate
3.6.2 Global 5 and 10 Largest Prescription Weight Loss Pills Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Prescription Weight Loss Pills Industry Chain Analysis
4.1 Prescription Weight Loss Pills Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Prescription Weight Loss Pills Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Prescription Weight Loss Pills Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Prescription Weight Loss Pills Sales Market Share by Type (2019-2025)
6.3 Global Prescription Weight Loss Pills Market Size Market Share by Type (2019-2025)
6.4 Global Prescription Weight Loss Pills Price by Type (2019-2025)
7 Prescription Weight Loss Pills Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Prescription Weight Loss Pills Market Sales by Application (2019-2025)
7.3 Global Prescription Weight Loss Pills Market Size (M USD) by Application (2019-2025)
7.4 Global Prescription Weight Loss Pills Sales Growth Rate by Application (2019-2025)
8 Prescription Weight Loss Pills Market Consumption by Region
8.1 Global Prescription Weight Loss Pills Sales by Region
8.1.1 Global Prescription Weight Loss Pills Sales by Region
8.1.2 Global Prescription Weight Loss Pills Sales Market Share by Region
8.2 North America
8.2.1 North America Prescription Weight Loss Pills Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Prescription Weight Loss Pills Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Prescription Weight Loss Pills Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Prescription Weight Loss Pills Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Prescription Weight Loss Pills Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Prescription Weight Loss Pills Market Production by Region
9.1 Global Production of Prescription Weight Loss Pills by Region (2019-2025)
9.2 Global Prescription Weight Loss Pills Revenue Market Share by Region (2019-2025)
9.3 Global Prescription Weight Loss Pills Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Prescription Weight Loss Pills Production
9.4.1 North America Prescription Weight Loss Pills Production Growth Rate (2019-2025)
9.4.2 North America Prescription Weight Loss Pills Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Prescription Weight Loss Pills Production
9.5.1 Europe Prescription Weight Loss Pills Production Growth Rate (2019-2025)
9.5.2 Europe Prescription Weight Loss Pills Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Prescription Weight Loss Pills Production (2019-2025)
9.6.1 Japan Prescription Weight Loss Pills Production Growth Rate (2019-2025)
9.6.2 Japan Prescription Weight Loss Pills Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Prescription Weight Loss Pills Production (2019-2025)
9.7.1 China Prescription Weight Loss Pills Production Growth Rate (2019-2025)
9.7.2 China Prescription Weight Loss Pills Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Currax Pharmaceuticals (Contrave)
10.1.1 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Basic Information
10.1.2 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product Overview
10.1.3 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product Market Performance
10.1.4 Currax Pharmaceuticals (Contrave) Business Overview
10.1.5 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills SWOT Analysis
10.1.6 Currax Pharmaceuticals (Contrave) Recent Developments
10.2 VIVUS (Qsymia)
10.2.1 VIVUS (Qsymia) Prescription Weight Loss Pills Basic Information
10.2.2 VIVUS (Qsymia) Prescription Weight Loss Pills Product Overview
10.2.3 VIVUS (Qsymia) Prescription Weight Loss Pills Product Market Performance
10.2.4 VIVUS (Qsymia) Business Overview
10.2.5 VIVUS (Qsymia) Prescription Weight Loss Pills SWOT Analysis
10.2.6 VIVUS (Qsymia) Recent Developments
10.3 Novo Nordisk A/S
10.3.1 Novo Nordisk A/S Prescription Weight Loss Pills Basic Information
10.3.2 Novo Nordisk A/S Prescription Weight Loss Pills Product Overview
10.3.3 Novo Nordisk A/S Prescription Weight Loss Pills Product Market Performance
10.3.4 Novo Nordisk A/S Prescription Weight Loss Pills SWOT Analysis
10.3.5 Novo Nordisk A/S Business Overview
10.3.6 Novo Nordisk A/S Recent Developments
10.4 Rhythm Pharmaceuticals (Imcivree)
10.4.1 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Basic Information
10.4.2 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product Overview
10.4.3 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product Market Performance
10.4.4 Rhythm Pharmaceuticals (Imcivree) Business Overview
10.4.5 Rhythm Pharmaceuticals (Imcivree) Recent Developments
10.5 Eli Lilly and Company (TRICARE)
10.5.1 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Basic Information
10.5.2 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product Overview
10.5.3 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product Market Performance
10.5.4 Eli Lilly and Company (TRICARE) Business Overview
10.5.5 Eli Lilly and Company (TRICARE) Recent Developments
10.6 CHEPLAPHARM (Xenical)
10.6.1 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Basic Information
10.6.2 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product Overview
10.6.3 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product Market Performance
10.6.4 CHEPLAPHARM (Xenical) Business Overview
10.6.5 CHEPLAPHARM (Xenical) Recent Developments
10.7 Pfizer
10.7.1 Pfizer Prescription Weight Loss Pills Basic Information
10.7.2 Pfizer Prescription Weight Loss Pills Product Overview
10.7.3 Pfizer Prescription Weight Loss Pills Product Market Performance
10.7.4 Pfizer Business Overview
10.7.5 Pfizer Recent Developments
10.8 Teva Pharmaceutical (Actavis)
10.8.1 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Basic Information
10.8.2 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product Overview
10.8.3 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product Market Performance
10.8.4 Teva Pharmaceutical (Actavis) Business Overview
10.8.5 Teva Pharmaceutical (Actavis) Recent Developments
10.9 Haleon Group (alli)
10.9.1 Haleon Group (alli) Prescription Weight Loss Pills Basic Information
10.9.2 Haleon Group (alli) Prescription Weight Loss Pills Product Overview
10.9.3 Haleon Group (alli) Prescription Weight Loss Pills Product Market Performance
10.9.4 Haleon Group (alli) Business Overview
10.9.5 Haleon Group (alli) Recent Developments
10.10 Sanofi (Adlyxin)
10.10.1 Sanofi (Adlyxin) Prescription Weight Loss Pills Basic Information
10.10.2 Sanofi (Adlyxin) Prescription Weight Loss Pills Product Overview
10.10.3 Sanofi (Adlyxin) Prescription Weight Loss Pills Product Market Performance
10.10.4 Sanofi (Adlyxin) Business Overview
10.10.5 Sanofi (Adlyxin) Recent Developments
10.11 AstraZeneca (BYDUREON BCise)
10.11.1 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Basic Information
10.11.2 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product Overview
10.11.3 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product Market Performance
10.11.4 AstraZeneca (BYDUREON BCise) Business Overview
10.11.5 AstraZeneca (BYDUREON BCise) Recent Developments
11 Prescription Weight Loss Pills Market Forecast by Region
11.1 Global Prescription Weight Loss Pills Market Size Forecast
11.2 Global Prescription Weight Loss Pills Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Prescription Weight Loss Pills Market Size Forecast by Country
11.2.3 Asia Pacific Prescription Weight Loss Pills Market Size Forecast by Region
11.2.4 South America Prescription Weight Loss Pills Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Prescription Weight Loss Pills by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Prescription Weight Loss Pills Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Prescription Weight Loss Pills by Type (2025-2032)
12.1.2 Global Prescription Weight Loss Pills Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Prescription Weight Loss Pills by Type (2025-2032)
12.2 Global Prescription Weight Loss Pills Market Forecast by Application (2025-2032)
12.2.1 Global Prescription Weight Loss Pills Sales (K MT) Forecast by Application
12.2.2 Global Prescription Weight Loss Pills Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Prescription Weight Loss Pills Market Size Comparison by Region (M USD)
Table 5. Global Prescription Weight Loss Pills Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Prescription Weight Loss Pills Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Prescription Weight Loss Pills Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Prescription Weight Loss Pills Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Weight Loss Pills as of 2022)
Table 10. Global Market Prescription Weight Loss Pills Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Prescription Weight Loss Pills Sales Sites and Area Served
Table 12. Manufacturers Prescription Weight Loss Pills Product Type
Table 13. Global Prescription Weight Loss Pills Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Prescription Weight Loss Pills
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Prescription Weight Loss Pills Market Challenges
Table 22. Global Prescription Weight Loss Pills Sales by Type (K MT)
Table 23. Global Prescription Weight Loss Pills Market Size by Type (M USD)
Table 24. Global Prescription Weight Loss Pills Sales (K MT) by Type (2019-2025)
Table 25. Global Prescription Weight Loss Pills Sales Market Share by Type (2019-2025)
Table 26. Global Prescription Weight Loss Pills Market Size (M USD) by Type (2019-2025)
Table 27. Global Prescription Weight Loss Pills Market Size Share by Type (2019-2025)
Table 28. Global Prescription Weight Loss Pills Price (USD/MT) by Type (2019-2025)
Table 29. Global Prescription Weight Loss Pills Sales (K MT) by Application
Table 30. Global Prescription Weight Loss Pills Market Size by Application
Table 31. Global Prescription Weight Loss Pills Sales by Application (2019-2025) & (K MT)
Table 32. Global Prescription Weight Loss Pills Sales Market Share by Application (2019-2025)
Table 33. Global Prescription Weight Loss Pills Sales by Application (2019-2025) & (M USD)
Table 34. Global Prescription Weight Loss Pills Market Share by Application (2019-2025)
Table 35. Global Prescription Weight Loss Pills Sales Growth Rate by Application (2019-2025)
Table 36. Global Prescription Weight Loss Pills Sales by Region (2019-2025) & (K MT)
Table 37. Global Prescription Weight Loss Pills Sales Market Share by Region (2019-2025)
Table 38. North America Prescription Weight Loss Pills Sales by Country (2019-2025) & (K MT)
Table 39. Europe Prescription Weight Loss Pills Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Prescription Weight Loss Pills Sales by Region (2019-2025) & (K MT)
Table 41. South America Prescription Weight Loss Pills Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Prescription Weight Loss Pills Sales by Region (2019-2025) & (K MT)
Table 43. Global Prescription Weight Loss Pills Production (K MT) by Region (2019-2025)
Table 44. Global Prescription Weight Loss Pills Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Prescription Weight Loss Pills Revenue Market Share by Region (2019-2025)
Table 46. Global Prescription Weight Loss Pills Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Prescription Weight Loss Pills Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Prescription Weight Loss Pills Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Prescription Weight Loss Pills Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Prescription Weight Loss Pills Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Basic Information
Table 52. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product Overview
Table 53. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Currax Pharmaceuticals (Contrave) Business Overview
Table 55. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills SWOT Analysis
Table 56. Currax Pharmaceuticals (Contrave) Recent Developments
Table 57. VIVUS (Qsymia) Prescription Weight Loss Pills Basic Information
Table 58. VIVUS (Qsymia) Prescription Weight Loss Pills Product Overview
Table 59. VIVUS (Qsymia) Prescription Weight Loss Pills Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. VIVUS (Qsymia) Business Overview
Table 61. VIVUS (Qsymia) Prescription Weight Loss Pills SWOT Analysis
Table 62. VIVUS (Qsymia) Recent Developments
Table 63. Novo Nordisk A/S Prescription Weight Loss Pills Basic Information
Table 64. Novo Nordisk A/S Prescription Weight Loss Pills Product Overview
Table 65. Novo Nordisk A/S Prescription Weight Loss Pills Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Novo Nordisk A/S Prescription Weight Loss Pills SWOT Analysis
Table 67. Novo Nordisk A/S Business Overview
Table 68. Novo Nordisk A/S Recent Developments
Table 69. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Basic Information
Table 70. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product Overview
Table 71. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Rhythm Pharmaceuticals (Imcivree) Business Overview
Table 73. Rhythm Pharmaceuticals (Imcivree) Recent Developments
Table 74. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Basic Information
Table 75. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product Overview
Table 76. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Eli Lilly and Company (TRICARE) Business Overview
Table 78. Eli Lilly and Company (TRICARE) Recent Developments
Table 79. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Basic Information
Table 80. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product Overview
Table 81. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. CHEPLAPHARM (Xenical) Business Overview
Table 83. CHEPLAPHARM (Xenical) Recent Developments
Table 84. Pfizer Prescription Weight Loss Pills Basic Information
Table 85. Pfizer Prescription Weight Loss Pills Product Overview
Table 86. Pfizer Prescription Weight Loss Pills Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Pfizer Business Overview
Table 88. Pfizer Recent Developments
Table 89. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Basic Information
Table 90. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product Overview
Table 91. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Teva Pharmaceutical (Actavis) Business Overview
Table 93. Teva Pharmaceutical (Actavis) Recent Developments
Table 94. Haleon Group (alli) Prescription Weight Loss Pills Basic Information
Table 95. Haleon Group (alli) Prescription Weight Loss Pills Product Overview
Table 96. Haleon Group (alli) Prescription Weight Loss Pills Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Haleon Group (alli) Business Overview
Table 98. Haleon Group (alli) Recent Developments
Table 99. Sanofi (Adlyxin) Prescription Weight Loss Pills Basic Information
Table 100. Sanofi (Adlyxin) Prescription Weight Loss Pills Product Overview
Table 101. Sanofi (Adlyxin) Prescription Weight Loss Pills Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Sanofi (Adlyxin) Business Overview
Table 103. Sanofi (Adlyxin) Recent Developments
Table 104. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Basic Information
Table 105. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product Overview
Table 106. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. AstraZeneca (BYDUREON BCise) Business Overview
Table 108. AstraZeneca (BYDUREON BCise) Recent Developments
Table 109. Global Prescription Weight Loss Pills Sales Forecast by Region (2025-2032) & (K MT)
Table 110. Global Prescription Weight Loss Pills Market Size Forecast by Region (2025-2032) & (M USD)
Table 111. North America Prescription Weight Loss Pills Sales Forecast by Country (2025-2032) & (K MT)
Table 112. North America Prescription Weight Loss Pills Market Size Forecast by Country (2025-2032) & (M USD)
Table 113. Europe Prescription Weight Loss Pills Sales Forecast by Country (2025-2032) & (K MT)
Table 114. Europe Prescription Weight Loss Pills Market Size Forecast by Country (2025-2032) & (M USD)
Table 115. Asia Pacific Prescription Weight Loss Pills Sales Forecast by Region (2025-2032) & (K MT)
Table 116. Asia Pacific Prescription Weight Loss Pills Market Size Forecast by Region (2025-2032) & (M USD)
Table 117. South America Prescription Weight Loss Pills Sales Forecast by Country (2025-2032) & (K MT)
Table 118. South America Prescription Weight Loss Pills Market Size Forecast by Country (2025-2032) & (M USD)
Table 119. Middle East and Africa Prescription Weight Loss Pills Consumption Forecast by Country (2025-2032) & (Units)
Table 120. Middle East and Africa Prescription Weight Loss Pills Market Size Forecast by Country (2025-2032) & (M USD)
Table 121. Global Prescription Weight Loss Pills Sales Forecast by Type (2025-2032) & (K MT)
Table 122. Global Prescription Weight Loss Pills Market Size Forecast by Type (2025-2032) & (M USD)
Table 123. Global Prescription Weight Loss Pills Price Forecast by Type (2025-2032) & (USD/MT)
Table 124. Global Prescription Weight Loss Pills Sales (K MT) Forecast by Application (2025-2032)
Table 125. Global Prescription Weight Loss Pills Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Prescription Weight Loss Pills
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Prescription Weight Loss Pills Market Size (M USD), 2019-2032
Figure 5. Global Prescription Weight Loss Pills Market Size (M USD) (2019-2032)
Figure 6. Global Prescription Weight Loss Pills Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Prescription Weight Loss Pills Market Size by Country (M USD)
Figure 11. Prescription Weight Loss Pills Sales Share by Manufacturers in 2023
Figure 12. Global Prescription Weight Loss Pills Revenue Share by Manufacturers in 2023
Figure 13. Prescription Weight Loss Pills Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Prescription Weight Loss Pills Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Prescription Weight Loss Pills Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Prescription Weight Loss Pills Market Share by Type
Figure 18. Sales Market Share of Prescription Weight Loss Pills by Type (2019-2025)
Figure 19. Sales Market Share of Prescription Weight Loss Pills by Type in 2023
Figure 20. Market Size Share of Prescription Weight Loss Pills by Type (2019-2025)
Figure 21. Market Size Market Share of Prescription Weight Loss Pills by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Prescription Weight Loss Pills Market Share by Application
Figure 24. Global Prescription Weight Loss Pills Sales Market Share by Application (2019-2025)
Figure 25. Global Prescription Weight Loss Pills Sales Market Share by Application in 2023
Figure 26. Global Prescription Weight Loss Pills Market Share by Application (2019-2025)
Figure 27. Global Prescription Weight Loss Pills Market Share by Application in 2023
Figure 28. Global Prescription Weight Loss Pills Sales Growth Rate by Application (2019-2025)
Figure 29. Global Prescription Weight Loss Pills Sales Market Share by Region (2019-2025)
Figure 30. North America Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Prescription Weight Loss Pills Sales Market Share by Country in 2023
Figure 32. U.S. Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Prescription Weight Loss Pills Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Prescription Weight Loss Pills Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Prescription Weight Loss Pills Sales Market Share by Country in 2023
Figure 37. Germany Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Prescription Weight Loss Pills Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Prescription Weight Loss Pills Sales Market Share by Region in 2023
Figure 44. China Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Prescription Weight Loss Pills Sales and Growth Rate (K MT)
Figure 50. South America Prescription Weight Loss Pills Sales Market Share by Country in 2023
Figure 51. Brazil Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Prescription Weight Loss Pills Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Prescription Weight Loss Pills Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Prescription Weight Loss Pills Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Prescription Weight Loss Pills Production Market Share by Region (2019-2025)
Figure 62. North America Prescription Weight Loss Pills Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Prescription Weight Loss Pills Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Prescription Weight Loss Pills Production (K MT) Growth Rate (2019-2025)
Figure 65. China Prescription Weight Loss Pills Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Prescription Weight Loss Pills Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Prescription Weight Loss Pills Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Prescription Weight Loss Pills Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Prescription Weight Loss Pills Market Share Forecast by Type (2025-2032)
Figure 70. Global Prescription Weight Loss Pills Sales Forecast by Application (2025-2032)
Figure 71. Global Prescription Weight Loss Pills Market Share Forecast by Application (2025-2032)
